132 related articles for article (PubMed ID: 7735728)
1. The cytoprotective effect of the immunomodulator AS101 against hydrochloride induced gastric lesions.
Xu RH; Kalechman Y; Albeck M; Sredni B
Res Commun Mol Pathol Pharmacol; 1995 Jan; 87(1):4-20. PubMed ID: 7735728
[TBL] [Abstract][Full Text] [Related]
2. Effect of the immunomodulator AS101 on chemotherapy-induced multilineage myelosuppression, thrombocytopenia, and anemia in mice.
Kalechman Y; Rushkin G; Nerubay J; Albeck M; Sredni B
Exp Hematol; 1995 Dec; 23(13):1358-66. PubMed ID: 7498364
[TBL] [Abstract][Full Text] [Related]
3. Anti-IL-10 therapeutic strategy using the immunomodulator AS101 in protecting mice from sepsis-induced death: dependence on timing of immunomodulating intervention.
Kalechman Y; Gafter U; Gal R; Rushkin G; Yan D; Albeck M; Sredni B
J Immunol; 2002 Jul; 169(1):384-92. PubMed ID: 12077268
[TBL] [Abstract][Full Text] [Related]
4. Induction of acute phase proteins in mice and humans by treatment with AS101, an immunomodulator with radioprotective properties.
Kalechman Y; Shani A; Albeck M; Sredni B
Immunopharmacology; 1995 Mar; 29(2):149-58. PubMed ID: 7539780
[TBL] [Abstract][Full Text] [Related]
5. Protective and restorative role of AS101 in combination with chemotherapy.
Kalechman Y; Albeck M; Oron M; Sobelman D; Gurwith M; Horwith G; Kirsch T; Maida B; Sehgal SN; Sredni B
Cancer Res; 1991 Mar; 51(5):1499-503. PubMed ID: 1997189
[TBL] [Abstract][Full Text] [Related]
6. Adaptive gastric cytoprotection is mediated by prostaglandin EP1 receptors: a study using rats and knockout mice.
Takeuchi K; Araki H; Umeda M; Komoike Y; Suzuki K
J Pharmacol Exp Ther; 2001 Jun; 297(3):1160-5. PubMed ID: 11356942
[TBL] [Abstract][Full Text] [Related]
7. The immunomodulator AS101 administered orally as a chemoprotective and radioprotective agent.
Sredni B; Albeck M; Kazimirsky G; Shalit F
Int J Immunopharmacol; 1992 May; 14(4):613-9. PubMed ID: 1521929
[TBL] [Abstract][Full Text] [Related]
8. Role of endogenous cytokines secretion in radioprotection conferred by the immunomodulator ammonium trichloro(dioxyethylene-0-0')tellurate.
Kalechman Y; Zuloff A; Albeck M; Strassmann G; Sredni B
Blood; 1995 Mar; 85(6):1555-61. PubMed ID: 7888674
[TBL] [Abstract][Full Text] [Related]
9. Antibabesial effect of the immunomodulator AS101 in mice: role of increased production of nitric oxide.
Rosenblatt-Bin H; Klein A; Sredni B
Parasite Immunol; 1996 Jun; 18(6):297-306. PubMed ID: 9229382
[TBL] [Abstract][Full Text] [Related]
10. The protective role of the immunomodulator AS101 against chemotherapy-induced alopecia studies on human and animal models.
Sredni B; Xu RH; Albeck M; Gafter U; Gal R; Shani A; Tichler T; Shapira J; Bruderman I; Catane R; Kaufman B; Whisnant JK; Mettinger KL; Kalechman Y
Int J Cancer; 1996 Jan; 65(1):97-103. PubMed ID: 8543404
[TBL] [Abstract][Full Text] [Related]
11. Cytoprotective effect of sofalcone in the rat gastric mucosa.
Isobe Y; Hirose H; Muramatsu M; Aihara H
Arzneimittelforschung; 1985; 35(1):138-41. PubMed ID: 3857044
[TBL] [Abstract][Full Text] [Related]
12. Acetazolamide interferes with the protective effect of prostaglandin E2 in the rat gastric mucosa.
Kollberg B; Aly A; Rubio C; Johansson C
Scand J Gastroenterol; 1981 Apr; 16(3):385-7. PubMed ID: 16435480
[TBL] [Abstract][Full Text] [Related]
13. Cytokine secretion effected by synergism of the immunomodulator AS101 and the protein kinase C inducer bryostatin.
Sredni B; Kalechman Y; Albeck M; Gross O; Aurbach D; Sharon P; Sehgal SN; Gurwith MJ; Michlin H
Immunology; 1990 Aug; 70(4):473-7. PubMed ID: 2118479
[TBL] [Abstract][Full Text] [Related]
14. The immunomodulator AS101 restores T(H1) type of response suppressed by Babesia rodhaini in BALB/c mice.
Rosenblatt-Bin H; Kalechman Y; Vonsover A; Xu RH; Da JP; Shalit F; Huberman M; Klein A; Strassmann G; Albeck M; Sredni B
Cell Immunol; 1998 Feb; 184(1):12-25. PubMed ID: 9626331
[TBL] [Abstract][Full Text] [Related]
15. Radioprotective effects of the immunomodulator AS101.
Kalechman Y; Albeck M; Oron M; Sobelman D; Gurwith M; Seghal SN; Sredni B
J Immunol; 1990 Sep; 145(5):1512-7. PubMed ID: 2384668
[TBL] [Abstract][Full Text] [Related]
16. The protective role of ammonium trichloro(dioxoethylene-O,O')tellurate in combination with several cytotoxic drugs acting by different mechanisms of action.
Kalechman Y; Shani A; Sotnik-Barkai I; Albeck M; Sredni B
Cancer Res; 1993 Dec; 53(24):5962-9. PubMed ID: 8261410
[TBL] [Abstract][Full Text] [Related]
17. Protection of bone marrow stromal cells from the toxic effects of cyclophosphamide in vivo and of ASTA-Z 7557 and etoposide in vitro by ammonium trichloro(dioxyethylene-O-O')tellurate (AS101).
Kalechman Y; Sotnik-Barkai I; Albeck M; Sredni B
Cancer Res; 1993 Apr; 53(8):1838-44. PubMed ID: 8467503
[TBL] [Abstract][Full Text] [Related]
18. Antiulcer principle from Zingiber montanum.
Al-Amin M; Sultana GN; Hossain CF
J Ethnopharmacol; 2012 May; 141(1):57-60. PubMed ID: 22366683
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin, tumor necrosis factor alpha and neutrophils: causative relationship in indomethacin-induced stomach injuries.
Ding SZ; Lam SK; Yuen ST; Wong BC; Hui WM; Ho J; Guo X; Cho CH
Eur J Pharmacol; 1998 May; 348(2-3):257-63. PubMed ID: 9652341
[TBL] [Abstract][Full Text] [Related]
20. Differential effect of the immunomodulator AS101 on B7-1 and B7-2 costimulatory molecules: role in the antitumoral effects of AS101.
Kalechman Y; Sredni B
J Immunol; 1996 Jul; 157(2):589-97. PubMed ID: 8752906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
